The two tests are also being considered for inclusion in a multicenter study of pediatric malignancies led by Dana Farber Cancer Institute (The Genomic Assessment Informs Novel Therapy (GAIN) Consortium Individualized Cancer Therapy 2, iCat2 Study). (newsroom.cumc.columbia.edu)
Dr. Cole's research interests include cancer genomics and the identification of molecularly targeted therapies for pediatric malignancies. (sciencemag.org)
Recognizing a need to further explore genomic profiling in pediatric malignancies, the Hugs for Brady Foundation has committed $ 300,000 to the precision medicine initiative at Rutgers Cancer Institute of New Jersey. (sciencedaily.com)